CDC Report Highlights Need for Increased Awareness of HIV Prevention Pill

Why it matters locally: Pennsylvania, with a population of approximately 13 million, would benefit from increased PrEP awareness and accessibility, aligning with national efforts to reduce HIV transmission.

---

Atlanta - A recent report from the Centers for Disease Control and Prevention (CDC) emphasizes the ongoing need to increase awareness and utilization of pre-exposure prophylaxis (PrEP), a daily medication that can prevent HIV infection. The "Vital Signs" report from the CDC focuses on the gap between the availability of PrEP and its adoption among those who could benefit most. PrEP is a preventative measure involving a daily pill regimen designed to reduce the risk of HIV acquisition. The CDC report did not specify particular groups or regions where PrEP usage is lacking, but instead focused on the overall need for increased awareness to ensure vulnerable populations can access this preventative option.